1. Moller PL, Sindet- Pedersen S, Petersen CT, et al: Onset of acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery. Br J Anaesth 2005 ; 94 : 642 - 648
2. Kumagai Y. Placebo- controlled, double- blind study to evaluate the safety, tolerability, and pharmacokinetics of intravenous acetaminophen formulation ( TRM- 1106 ) in Japanese heal thy subjects. J Clin Therap Med 2013 ; 29 : 875 – 887
3. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. New Engl J Med 1999 ; 340 : 1888 – 1899
4. Castellsague J , Riera- Guardia N, Calingaert B, et al: Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta - analysis of observational studies ( the SOS project). Drug Saf 2012 ; 35 : 1127 – 1146
5. De Abajo FJ, Gil MJ, Bryant V , et al: Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case – control study in a new general practice database. Eur J Clin Pharmacol 2013 ; 69 : 691 – 701
6. Hahn TW, Mogensen T, Lund C , et al: Analgesic effect of i . v. paracetamol: possible ceiling effect of par acetamol in postoperative pain. Acta Anaethesiol Scand. 2003 ; 47 : 138 - 145
7. Anderson BJ ， Holford NH, Woollard GA ， et al: Perioperative pharmacodynamics of acetaminophen analgesia in chil dren. Anesthesiology 1999 ; 90 : 411 - 421
8. Beck DH, Schenk MR, Hagemann K, et al: The pharmacokinetics and analgesic efficacy of larger dose rectal acetaminophen ( 40 mg/ kg) in adults: a double- blinded, randomized study. Anesth Analg . 2000 ; 90 : 431 - 436
9. Brett CN, Barnett SG, Pearson JP. Postoperative plasma paracetamol levels following oral or intravenous paracetamol administration: a double - blind randomized controlled trial. Anaesth Intensive Care 2012 ; 40 : 166 - 171
10. Luthy CS, Collart L, Payer P. Administration profi le controls acetaminophen analgesia. Clin Pharmacol Ther 1993 ; 53 : PII – 3
11. Singla NK, Parulan C, Samson R, et al: Plasma and cerebrospinal f luid pharmacokinetic parameters after s ingle dose administration of intravenous, oral, or rectal acetaminophen. Pain Pract 2012 ; 12 : 523 – 532
12. Nielsen JC, Bjer r ing P, Arend- Nielsen L, et al: Analgesic efficacy of immediate and sustained release paracetamol and plasma concentration of paracetamol. Double blind, placebo - controlled evaluation using painful laser stimulation. Eur J Clin Pharmacol 1992 : 42 : 261 - 264
13. Imaizumi T, Obara S, Mogami M, et al: Poulation pharmacokinetics of intravenous acetaminophen in Japanese patients underg oing elective surgery. J Anesth 2017 ; 31 : 380 - 388
14. Seymour RA, Rawlins MD. Pharmacokinetics of parenteral paracetamol and i ts analgesic effects in post - operative dental pain. Eur J Clin Pharmacol 1981 ; 20 : 215 – 8
15. Gibb IA, Anderson BJ. Paracetamol ( acetaminophen) pharmacodynamics: interpreting the plasma concentration. Arch Dis Child 2008 ; 93 : 241 - 247
16. Bailey DN, Briggs JR. The binding of acetaminophen, l idocaine, and valproic acid to human milk. Am J Clin Pathol 2004 ; 121 : 754 – 757
17. Slattery JT, Mc Rorie TI, Reynolds R, et al: Lack of effect of cimetidine on acetaminophen disposition in humans. Clin Phar macol Ther 1989 ; 46 : 591 - 597
18. Miners JO, Osborne NJ, Tonkin AL, et al: Perturbation of paracetamol urinary metabolic ratios by uri ne f low rate. Br. J . cl in. Pharmac 1992 ; 34 : 359 - 362
19. Mitchell JR, Jollow DJ, Potter WZ, et al: Acetaminophen- induced hepatic necrosis. IV. Protective role of gl utathione. J Pharmacol Exp Ther 1973 ; 187 : 211 - 217
20. Mitchell JR, Thorgeirsson SS, P otter WZ, et al : Acetaminophen ‐ induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther 1974 : 16 : 676 - 684
21. アセトアミノフェン中毒 福本真理子 中毒研究 2003 ; 16 ： 285 - 297
22. Rumack BH, Matthew H. Acetaminophen Poi soning and Toxicity. Pediatrics 1975 ; 55 : 871 - 876
23. Royal M, Gosselin NH, Pan P, et al: Route of administration s ignificantly impacts hepatic acetaminophen exposure [ abstract]. Clin pharmacol Ther 2010; 87 : S 62
24. Barrière DA, Boumezbeur F, Dalmann R, et al: Paracetamol is a centrally acting analgesic using mechanisms located in the periaquedu ctal grey. Br J Pharmacol 2020 ; 177 : 1773 – 179
25. Shun Muramatsu, Seiji Shiraishi, Kanako Miyano, et al: Metabolism of AM 404 from Acetaminophen at human therapeutic dosages in the rat brain. Anesth Pain Med 2016 ; 6 ( 1 ) : e 32873
26. Klinger- Gratz PP , Ralvenius WT, Neumann E, et al: Acetaminophen relieves inflammatory pain through CB 1 cannabinoid receptors in the rostral ventromedial m edulla. The Journal of Neuroscience 2018 ; 38 : 322 – 334
27. Högestätt ED, Jönsson BA, Ermund A, et al: Conversion of acetaminophen to the bioactive N- acylphenolamine AM 404 via fatty acid amide hydrolase - dependent arachidonic acid conjugation in the nervous system. J Biol Chem 2005 ; 280 : 31405 - 31412
28. Sharma CV, Long JH, Shah S, et al : First evidence of the conversion of paracetamol to AM 404 in human cerebrospinal f luid. J Pain Res 2017 ; 10 : 2703 - 2709
29. Deutsch DG, Ueda N, Yamamoto S. The fatty acid amide hydrolase （ FAAH ）. Prostaglandins Leukot Essent Fatty Acids. 2002 ; 66 : 201-10
30. Ruggieri V, Vitale G, Pini LA, et al: Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N - arachidonoyl- phenolamine ( AM 404 ) in the rat: comparison with paracetamol. Nauny n Schmiedebergs Arch Pharmacol 2008 ; 377 : 219 - 29
論文の公開元へ
